UCSF Edward and Pearl Fein Memory and Aging Center

Running trials

• Enrolling by invitation

  Alzheimer's Tau Platform: Regimen A - AADvac1

  NCT07167966· Phase 2· Paul S. Aisen· Source

• Enrolling by invitation

  The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1

  NCT07217665· Phase 2· Adam Boxer· Source

• Enrolling by invitation

  The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31

  NCT07264283· Phase 2· Adam Boxer· Source

• Active, not recruiting

  A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07169578· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  NCT07033494· Phase 2· Merck Sharp & Dohme LLC· Source

• Active, not recruiting

  Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology

  NCT05184569· Phase 1· Peter Ljubenkov, MD· Source

• Active, not recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  NCT04437511· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

  NCT03887455· Phase 3· Eisai Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting

Closed trials

• Terminated

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· Phase 3· Biogen· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Frontotemporal dementia12 works · 1 trial